2 8 1 CD4 + T cells are commonly classified as 'helper' T cells on the basis of their roles in providing help to promote or dampen cellular and humoral immune responses. In contrast, CD8αβ + cytotoxic T lympho cytes (CTLs) provide direct protective immunity by killing infected or transformed cells. The helper T cell program is initially induced during thymic development, during which thymocytes expressing a major histocompatibility complex (MHC) class II-reactive T cell antigen receptor (TCR) develop into the CD4 + helper T cell lineage, whereas thymocytes with specificity for MHC class I differentiate into the CD8 + CTL lineage. The functional programming, which coincides with but does not depend on the MHC restriction or expression of the coreceptor CD4 or CD8αβ, is controlled by the action and counter action of key transcription factors. Together with Tox and GATA3, the helper T cell transcription factor ThPOK (cKrox; encoded by Zbtb7b (called 'Thpok' here)) first induces the CD4 + helper T cell fate and prevents thymocytes from differentiating into CD8 + CTLs 1-6 . Runx3, a member of the Runx family of transcription factors, has the opposite effect and terminates CD4 expression while promoting differentiation into the CTL lineage 7, 8 . The CD8CD4 lineage dichotomy persists in the periphery for mature T cells, in which ThPOK continues to sup press the cytotoxic fate of MHC class II-restricted CD4 + T cells even as they differentiate into effector helper T cell subsets controlled by additional transcription factors 6 .
CD4 + T cells are commonly classified as 'helper' T cells on the basis of their roles in providing help to promote or dampen cellular and humoral immune responses. In contrast, CD8αβ + cytotoxic T lympho cytes (CTLs) provide direct protective immunity by killing infected or transformed cells. The helper T cell program is initially induced during thymic development, during which thymocytes expressing a major histocompatibility complex (MHC) class II-reactive T cell antigen receptor (TCR) develop into the CD4 + helper T cell lineage, whereas thymocytes with specificity for MHC class I differentiate into the CD8 + CTL lineage. The functional programming, which coincides with but does not depend on the MHC restriction or expression of the coreceptor CD4 or CD8αβ, is controlled by the action and counter action of key transcription factors. Together with Tox and GATA3, the helper T cell transcription factor ThPOK (cKrox; encoded by Zbtb7b (called 'Thpok' here)) first induces the CD4 + helper T cell fate and prevents thymocytes from differentiating into CD8 + CTLs [1] [2] [3] [4] [5] [6] . Runx3, a member of the Runx family of transcription factors, has the opposite effect and terminates CD4 expression while promoting differentiation into the CTL lineage 7, 8 . The CD8CD4 lineage dichotomy persists in the periphery for mature T cells, in which ThPOK continues to sup press the cytotoxic fate of MHC class II-restricted CD4 + T cells even as they differentiate into effector helper T cell subsets controlled by additional transcription factors 6 .
That lineage separation, however, is not all encompassing, and reports have repeatedly indicated the presence of CD4 + T cells with cytolytic functions in various species, including humans and rodents [9] [10] [11] [12] . At steady state, populations of the effector cells that reside in the intestine as intraepithelial lymphocytes (IELs) show enrich ment for cytotoxic T cells, including CD4 + T cells [13] [14] [15] , whereas under inflammatory conditions, including viral infections, autoimmune dis orders and in response to tumor antigens, many cytolytic CD4 + T cell populations expand in the blood and peripheral tissues [9] [10] [11] [12] 16, 17 . Their widespread abundance and participation in various beneficial as well as pathogenic adaptive immune responses [9] [10] [11] [12] 16, 17 underscore the physiological relevance of cytolytic CD4 + effector cells. However, the generation of convincing evidence directly linking them to specific A r t i c l e s aspects of the adaptive immune response has been difficult, as they have been viewed merely as functional variants of the welldefined T helper type 1 (T H 1) subtype 12, 18 . The lack of a defined gene signa ture has also greatly impaired progress in elucidating the biology of cytolytic CD4 + T cells and in designing clinical strategies that specifi cally target these cells in various diseases.
Here we provide proof indicating that cytotoxic CD4 + T cells rep resent a distinct subset of effector cells that can be defined by the absence of the master regulator ThPOK, which maintains the helper T cell fate in all subsets of classical CD4 + helper T cells by continuously suppressing the CD8 + CTL lineage program 6 . Nevertheless, we also found that the ThPOK − CD4 + CTLs originated from ThPOKexpressing progenitor cells that initially committed to the ThPOKcontrolled helper T cell lineage during thymic selection. Our findings therefore challenge the view that the helper T cell program in CD4 + T cells is fixed and show that mature CD4 + T cells can lose ThPOK expression postthymically and can be functionally reprogrammed to become MHC class II-restricted CTLs. We also identify the Thpok silencer as the transcriptional switch that terminated Thpok transcription and by default drove the derepression of the CTL program in mature CD4 + effector cells. At steady state, CD4 + CTLs remained immunologically quiescent even in the continuous presence of their cognate antigens. However, in response to restimulation in the context of interleukin 15 (IL15), CD4 + CTLs greatly increased their inflammatory and cyto lytic functions and differentiated into potent killer effector cells.
Overall, our data demonstrate that CD4 + CTLs are not a simple vari ant of classical ThPOKcontrolled T H 1 cells but instead are distinct functional MHC class II-restricted effector cells that can be char acterized by the loss of ThPOK expression and the derepression of aspects of the geneexpression program of the CD8 + CTL lineage.
RESULTS

Not all mature CD4 + T cells express ThPOK
The reported cytolytic activity of mature CD4 + T cells is inconsistent with the idea that ThPOK continuously suppresses the CTL program in all mature, MHC class II-restricted CD4 + T cells 6 and suggests that these cells might not be under the negative control of ThPOK. To investigate this, we analyzed ThPOK expression in mature T cells isolated from reporter mice with sequence encoding green fluores cent protein (GFP) knocked in to the ThPOK locus (ThpokGFP mice) 19 . As expected, CD4 + ThpokGFP lymphocytes isolated from the spleen or mesenteric lymph nodes (mLNs), which are mostly naive T cells, were GFP + (Fig. 1a) , which indicated that they all expressed ThPOK, as is typical of mature cells of the CD4 + helper T cell line age. Conversely, all cells in the CD8 + fraction were GFP − (Fig. 1a) , consistent with the absence of ThPOK expression in cells of the CTL lineage. Unexpectedly, many of the ThpokGFP CD4 + effector T cells that accumulated in the intestine at steady state were GFP − (Fig. 1b,c) , which indicated that like their CD8 + counterparts, they did not express ThPOK. Notably, most of the GFP − CD4 + cells were in the subset of doublepositive (DP) IELs that coexpressed CD4 and CD8α without CD8β 20 ( Fig. 1b-d) . Consistent with the lack of ThPOKmediated suppression, these CD4 + CD8α + CD8β − cells also had functional features similar to those of mature CD8 + CTLs, including abundant expression of granzyme (Fig. 1e,f) and substantial expression of the activationinduced degranulation marker CD107a (LAMP1), a glyco protein present in the membrane of cytotoxic granules and exposed on the surface of activated cytolytic cells 21 (Fig. 1g,h ). The induction of CD107a by the DP subset was similar to that of typical TCRαβ + CD8 + CTLs, whereas activated CD4 + CD8α − singlepositive (SP) IELs or helper T cells from the spleen did not induce this cytolytic marker 
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( Fig. 1g,h ). Moreover, activated DP cells also effectively killed target cells in vitro, as measured by the release of lactate dehydrogenase after lysis of target cells ( Fig. 1i and Supplementary Fig. 1a) . In sum, these data demonstrated that in normal mice, not all CD4 + effector cells expressed ThPOK and, furthermore, that those ThPOK − CD4 + lym phocytes expressed CD8α (but not CD8β) and had cytolytic activity that closely resembled that of mature CD8 + CTLs.
Mature ThPOK − CD4 + T cells derive from ThPOK + thymocytes ThPOK is the master regulator of the helper T cell lineage and is first expressed in the thymus, where it counteracts Runx3 and suppresses the CTL fate of MHC class II-restricted thymocytes [4] [5] [6] . The absence of ThPOK expression associated with cytotoxicity in mature CD4 + T cells could suggest that they might have originated from ThPOK − progenitors. To investigate this, we designed a fatemapping mouse model in which we tracked previous ThPOK expression in mature T cell subsets (Fig. 2a) . Inactivation of Thpok transcription in MHC class I-specific thymocytes of the CD8 + CTL lineage is mediated by repressive factors, such as Runx proteins, that bind to the Thpok silencer DNA element 22, 23 . In MHC class II-restricted cells, however, ThPOK itself binds to the Thpok silencer and prevents Runxmediated silencing, which results in a positive feedback loop with continuous expression of Thpok (Fig. 2a) . A fate marker that reports any previous activity of the Thpok silencer in thymocytes is therefore an accurate reporter for the lineage origin and initial commitment of mature CD4 + T cells. On the basis of that rationale, we designed a mouse strain with transgenic expression of Cre recombinase, 'ThPOKCre' , in which a Thpok silencer inserted into a Cd4 enhancerpromoter locus controls expression of a transgene encoding Cre (Fig. 2a) .
In contrast to the widely used strain of mice that express Cre under the control of the Cd4 enhancerpromoter starting at the CD4 + CD8αβ + thymocyte stage, in ThPOKCre mice, the Thpok silencer prevents Cd4 enhancerpromoter activity in immature thymocytes and cells of the CD8 lineage, which results in Cre expression exclusively in mature CD4 + SP thymocytes committed to the helper T cell lineage (Fig. 2a) . Consistent with that, in progeny of a cross of ThPOKCre mice with reporter mice expressing yellow fluorescent protein (YFP) from the ubiquitous Rosa26 promoter (Rosa26YFP), we found that only cells derived from thymocytes that were committed to the CD4 + helper T cell lineage were marked by the expression of the YFP reporter after Cremediated recombination (Fig. 2b,c) . In those progeny of the Rosa26YFP × ThPOKCre cross, CD8 + SP thymocytes and mature peripheral CD8 + T cells, including CD4 − CD8 + mucosal T cells, did not express YFP, whereas, as expected, most CD4 + SP lymph node T cells and IELs were YFP + . Notably, CD8αexpressing CD4 + IELs were also YFP + , to an extent similar to that of conventional CD4 + SP cells (Fig. 2b,c) , which indicated that they had induced ThPOK dependent Cre expression and therefore that the mature ThPOK − CD4 + T cells must have been derived from progenitor cells that expressed ThPOK at an earlier stage.
ThPOK + CD4 + helper T cells lose ThPOK expression
The idea that the mature ThPOK − CD4 + cells previously expressed ThPOK, together with the observation that those cells mainly accu mulated among effector cells, suggested that the loss of ThPOK expression might have been the result of a postthymic activa tion or maturation process that mature T cells undergo in the periphery. To assess this, we adoptively transferred highly purified in the large intestine, and notably, also as DP effector cells, especially in the small intestine of the Rag1 −/− hosts ( Fig. 3a,b) . Donor cells in the spleen and mLNs were GFP + (Fig. 3c) , which indicated that they continued to express ThPOK. In contrast, many of the Thpok GFP CD4 + T cells that accumulated as effector cells in the intestine did not have detectable expression of GFP ( Fig. 3c) , which indicated that they had substantially diminished or complete loss of ThPOK expression. Consistent with the observations obtained with immuno logically replete mice, the loss of GFP expression was again greatest in those CD4 + cells that also reinduced CD8α expression, although a small fraction of CD4 + SP IELs were also GFP − (Fig. 3c,d ). Serial transfer of those SP donor cells into a second set of Rag1 −/− recipi ents generated many more DP cells (Fig. 3e) , which indicated that the reexpression of CD8α on mature CD4 + T cells followed the loss of ThPOK expression and further indicated that the Cd8a locus in conventional CD4 + helper T cells might be constitutively suppressed by ThPOK. To analyze this, we used chromatin immunoprecipitation (ChIP) combined with tiling arrays of cells from genetically engi neered mice that express Flaghemagglutinin epitope-tagged ThPOK (FHThPOK) from the Thpok locus 19 . FHThPOK associated with the E8 I enhancer element 24 in the Cd8a locus in SP CD4 + thymo cytes (Fig. 3f) . We also confirmed that result in mature CD4 + SP T cells by ChIP assay (Supplementary Fig. 2a ), which suggested that in mature CD4 + thymocytes and lymphocytes, ThPOK prevented CD8α expression by direct suppression of the E8 I enhancer element in the Cd8a locus, and also that the expression of CD8α without CD8β in mature ThPOK − CD4 + T cells was driven by derepression of the E8 I enhancer. In support of that finding, both the frequency of CD8αexpressing CD4 + IELs and CD8 expression itself were much lower in E8 I deficient mice than in wildtype mice (Fig. 3g) , a finding also true for the progeny of E8 I deficient cells versus wild type donor cells in Rag1 −/− recipients of an equal number of both genotypes of donor cells ( Fig. 3h and Supplementary Fig. 2b ). (Fig. 4a) , which indicated that their geneexpression profile was still regulated by the ThPOK. To examine the effect of the loss of ThPOK expression on the geneexpression pattern of CD4 + effector cells, we analyzed gene microarrays generated from RNA isolated from sorted ThPOK + or ThPOK − SP and DP effector cells from normal unmanipulated ThpokGFP reporter mice 19 ( Fig. 4b) and from Rag1 −/− recipients of naive ThpokGFP CD4 + SP donor cells ( Fig. 4c and Supplementary  Fig. 3a) . Notably, we found that DP and SP ThPOK − CD4 + T cells had a unique but similar geneexpression pattern that differed from that of SP ThPOK + CD4 + cells, although in the transfer experiments, the donor cells originated from the same pool of naive lymphocytes and differentiated in the same host environment (Fig. 4b,c and Supplementary Fig. 3a) . As expected, many of the ThPOK + CD4 + SP cells isolated from the intestine had a distinct T H 17 geneexpression pattern, whereas expression of those genes was barely detectable in the ThPOK − and DP subsets (Fig. 4b-d) . Furthermore, RTPCR analysis of genes characteristic of T H 17 cells, including those encoding the cytokines IL17A, IL17F and IL22, the cytokine receptor IL23R and the T H 17 hallmark nuclear transcription factor RORγt, con firmed that ThPOK − CD4 + effector cells were distinct from T H 17 cells (Fig. 4e,f and Supplementary Fig. 3b ). Moreover, analysis of genes characteristic of other CD4 + helper T cell types, such as T H 1 and T H 2 cells, demonstrated that the geneexpression pattern of CD4 + SP lymphocytes and DP lymphocytes that had lost ThPOK expression did not resemble the patterns of the known helper T cell effector subsets (Supplementary Fig. 3c ).
In contrast, in addition to reexpressing CD8α, ThPOK − CD4 + effector cells also expressed many other genes typically associated with the CD8 + CTL program. This included the expression of various genes encoding cytolytic proteins, such as several granzymes and perforin, as well as interferonγ (IFNγ) and several receptors expressed by natural killer cells and mature CD8 + CTLs (Fig. 4b,c,g,h and Supplementary  Fig. 3d,e) . Of particular note was their expression of the cytotoxicity related, MHC class I-restricted, T cell-associated molecule CRTAM and the CD2 family member CD244 (2B4), both known to promote the cytolytic function and IFNγ production of CD8 + T cells [25] [26] [27] .
The reciprocal expression in mature CD4 + effector cells of either ThPOK or CTL signature genes (Fig. 4i) (Fig. 4j) , whereas transfection of a construct encod ing Thpok with a spontaneous mutation found in the helperdeficient mouse strain 4 did not prevent the differentiation of helper T cells into CD4 + CTLs (Supplementary Fig. 3f ). These data indicated that the loss of ThPOK coincided with derepression of the CTL phenotype in mature CD4 + effector cells.
Thpok silencer derepression terminates Thpok expression
In thymocytes committed to the CD8 + CTL lineage, ThPOK expres sion is switched off at the transcriptional level by the Thpok silencer 22 . Consequently, in mice with germline deletion of this silencer (Thpok S∆/S∆ mice), MHC class I-restricted thymocytes mature as CD4expressing T cells in the periphery 22 . To determine if the Thpok silencer engages in a similar role to terminate Thpok expression in mature MHC class II-restricted precursors of CD4 + CTLs, we ana lyzed the peripheral maturation of CD4 + T cells in Thpok S∆/S∆ mice. To eliminate the MHC class I-restricted CD4expressing cells in these mice, we crossed the Thpok S∆/S∆ mice with MHC class I-deficient (β 2 microglobulindeficient (B2m −/− )) mice, which abrogated the development of MHC class I-restricted CD4 + CD8 + T cells. Notably, we found considerable enhancement of all CD4 + populations, includ ing DP IELs, in B2m −/− mice, in the absence of mature CD8 + T cells (Fig. 5a) ; however, Thpok S∆/S∆ B2m −/− mice had considerably fewer mature MHC class II-restricted CD8αexpressing CD4 + T cells (Fig. 5a ). These observations indicated that the Thpok silencer was a critical genomic switch in the process of the differentiation of CD4 + CTLs that turned off Thpok transcription in mature CD4 + T cells. We further confirmed that idea with CD4 + T cells in which a loxPflanked Thpok silencer (Thpok Sfl/Sfl ) was deleted at the mature stage by trans fection of the cells with a retroviral construct containing sequence encoding Cre linked to GFP. The transfer of transfected Thpok Sfl/Sfl CD4 + T cells (which expressed Cre (GFP + ) and consequently had deletion of the Thpok silencer) into Rag1 −/− recipient mice resulted in impaired accumulation of CD8αexpressing CD4 + CTLs in the intestine of the recipients (Fig. 5b) , which further emphasized the critical role of the Thpok silencer in terminating Thpok expression as part of the CTLdifferentiation process of CD4 + effector cells. In con trast to ThPOK, which suppresses the repressive activity of the Thpok silencer, the zincfinger transcription factor MAZR is known to acti vate the Thpok silencer 28 , which results in MAZRinduced negative regulation of Thpok transcription. Consistent with the participation of MAZR in reactivation of the Thpok silencer in mature CD4 T cells, MAZRdeficient CD4 + donor cells transferred into Rag1 −/− recipi ent mice formed fewer CD8αexpressing CD4 + CTLs than did their wildtype counterparts in the intestine of the recipients (Fig. 5c,d) . These results indicated that transcriptional regulation of Thpok was key for control of the helper T cell phenotype of mature CD4 + T cells and that reactivation of its silencer led to termination of the helper T cell program and, conversely, to the functional differentiation of MHC class II-restricted CD4 + CTLs. Despite that, however, we found significantly more CD8αexpressing CD4 + CTLs in mice deficient in the receptor for IL7 than in wild type mice (Fig. 6a) , which indicated that the in vivo differentiation of mature CD4 + CTLs was not an IL7driven process. Similar to other effector cells in the intestine, DP cells were not present in germfree mice (Supplementary Fig. 4a ) and seemed to be present in normal numbers in germfree mice reconstituted with specific pathogen-free microorganisms (Supplementary Fig. 4b ), which indicated that some microbial factors directly or indirectly promoted the accumulation of CD4 + CTLs in the intestine. In contrast, unlike classic CD4 + T H 17 effector cells, they did not increase in number in the intestine of germfree mice monocolonized with segmented filamentous bacteria alone 30 ( Supplementary Fig. 4b ) or in response to an infection with Citrobacter rodentium, a pathogen known to induce a strong T H 17 response in the large intestine (Supplementary Fig. 4c ), whereas they were present in normal numbers in the intestine of mice deficient in the adaptor MyD88. These observations indicated that the microbial conditions required for the steadystate accumulation of CD4 + CTLs in the intestine were probably not established by a single microorgan ism and did not depend on IL1 signals or signals induced by Tolllike receptors (Supplementary Fig. 4d ). Published reports have indicated that CD4 + CTLs are antigenexperienced cells that differentiate in response to repeated activation signals 10, 12 . In agreement with that, DP cells with a CTL phenotype isolated from Rag1 −/− recipients of naive spleen CD4 + SP T cells also showed evidence of strong or repeated activation and considerable uptake of the thymidine analog BrdU but only weak staining for the active cellcycle marker Ki67 (Fig. 6b) , which indicated that they were resting cells that had previously been activated and had previously intensely proliferated. In addition, CD4 + CTLs also had higher expression of the activation marker CD69 than did CD4 + SP effector helper T cells (Fig. 6b) , which suggested that the activation process that coincided with the loss of ThPOK expression and derepression of the CTL program also coincided with those CD4 + effector cells that received strong or repeated activation signals. To directly investigate that, we analyzed the effector differentiation of monoclonal OTII CD4 + T cells (which have transgenic expression of a TCR specific for ovalbumin amino acids 323-339 (OVA(323-339)) in response to continuous activation in vivo with their cognate peptide OVA(323-339) presented by IA b . T cells migrate as effector cells only to peripheral tissues, and in agreement with that, in the absence of OVA antigen, very few OTII CD4 + T cells accumulated in the intes tine of OTII mice. Similarly, after transfer of naive OTII CD4 + T cells into Rag1 −/− recipient mice, only a limited number of the donor cells migrated to the intestine of the recipient mice in the absence of OVA antigen (data not shown). In contrast, after mice were fed an OVA containing diet for at least 4 weeks, a large number of activated OTII CD4 + cells accumulated in the intestine of the OTII mice and the Rag1 −/− recipients, and, notably, many reexpressed CD8α (Fig. 6c) , whereas those that remained SP had a tendency to express the tran scription factor Foxp3 (Fig. 6c) . To determine if the derepression of CD8α expression on the responder OTII CD4 + T cells coincided with the loss of ThPOK and their differentiation into CTLs, we iso lated cells from OTII ThpokGFP reporter mice, transferred those naive donor cells into OVAfed Rag1 −/− recipient mice and analyzed the phenotype and function of the OVAresponding cells that accu mulated as effector cells in the intestine of the hosts. As expected, many OTII ThpokGFP DP cells accumulated in the small intes tine but, notably, they were all GFP − (Fig. 6d) , which indicated that they had lost ThPOK expression. Furthermore, in addition to the reexpression of CD8α, OTII GFP − effector cells also newly induced the expression of typical cytolytic markers, such as 2B4 and granzyme B (Supplementary Fig. 5a ). Notably, they had an antigenspecific cytolytic response when restimulated in vitro with the OTII TCRspecific peptide OVA(323-339) (Fig. 6e) but not when restimulated with the MHC class I-restricted OVA peptide SIINFEKL (amino acids 257-264; Supplementary Fig. 5b ).
CD4 + CTL differentiation is driven in vivo by antigen
Despite their functional potential, OTII ThPOK − CD4 + CTLs remained immunologically quiescent in vivo even in the continuous presence of their cognate antigen in the diet. That finding was simi lar to results obtained with MHC class I-restricted CD8αβ + CTLs, which also seem to be inactive under steadystate conditions 31 . After challenge with excess amounts of IL15, however, as in active celiac disease 18, 32 , CD8 + CTLs become pathogenic killer cells 33, 34 that also considerably upregulate secretion of the inflammatory cytokines IFNγ and tumornecrosis factor (TNF) 18,35,36, . To determine if CD4 + CTLs might be as responsive to IL15 as CD8 + CTLs, we restimulated the dietinduced OTII ThPOK − CD4 + CTLs in vitro in the context of IL15. As expected, the addition of IL15 resulted in higher CD8α expression 37 ; however, IL15 alone or together with the irrelevant MHC class I-restricted peptide SIINFEKL had no effect on the func tional differentiation or maturation of the MHC class II-restricted OTII CD4 + CTLs (Supplementary Fig. 5b ). In contrast, the addi tion of IL15 resulted in considerably enhanced immune responses of OVA(323-339)stimulated OTII ThPOK − CD4 + CTLs, as mea sured by the substantal upregulation of CD107a expression and the 
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A r t i c l e s much greater production of IFNγ and TNF (Fig. 6e) . These data therefore demonstrated that antigeninduced CD4 + CTLs generated in the absence of inflammation were poised to exert potent effector functions when reactivated by their cognate antigen in the context of the inflammatory cytokine IL15. We confirmed those data with polyclonal ThPOK − CD4 + CTLs isolated from the intestine of normal lymphocytesufficient mice and showed that unmanipulated CD4 + CTLs analyzed ex vivo also had the potential in response to polyclonal activation and to increase their cytolytic and inflammatory immune responses when exposed to IL15. Although IL15 alone supported shortterm survival of wildtype CD4 + CTLs and CD8αβ + CTLs, this cytokine alone did not induce cytolytic effector functions in these polyclonal cells (Supplementary Fig. 5c ). In contrast, similar to results obtained with the dietary antigen-induced OTII ThPOK − CD4 + CTLs or normal CD8αβ + CTLs (Supplementary Fig. 5d ), the addition of IL15 also resulted in considerably enhanced cytolytic and inflammatory functions of wildtype polyclonal TCRstimulated CD4 + CTLs, whereas it had only a negligible effect on ThPOK + CD4 + helper T cells (Fig. 6f) . These data emphasizes the likely pathogenic potential of antigeninduced ThPOK − CD4 + CTLs, which were poised to kill under conditions in which IL15 was abundant. The differentiation of CD4 + T lymphocytes into CTLs instead of their suppression and prevention from becoming inflammatory T H 1 or T H 17 cells makes teleological sense at epithelial interfaces, where rapid elimination of infected cells is important not only for resistance to the initial invasion of intracellular pathogens but also for limiting or preventing excessive infiltration of systemically activated cytokine secreting cells that could jeopardize the integrity of the mucosal bar rier 38 . In addition, the cytotoxic function of the CD4 + CTLs may also contribute to diminishing infection and inflammation by eliminating infected migratory dendritic cells that could further prime naive cells or mediate systemic spread of the pathogen.
DISCUSSION
The MHC class II restriction of CD4 + CTLs might render these lymphocytes able to restrain viral infections tropic for MHC class IIpositive target cells, including infected MHC class II-positive epi thelial cells 39 , EpsteinBarr virus-transformed B cells 40 or human immunodeficiency virus-infected human CD4 + T cells 41 . Such T cells might also be critical for protection against viruses, including human immunodeficiency virus and cytomegalovirus, that have developed mechanisms to escape surveillance by MHC class I-restricted CD8 + CTLs 40, 42 or under conditions in which the control response of CD8 + CTLs becomes exhausted, as is the case in many chronic infections. In addition, as with CD8αβ + CTLs, the responsiveness of CD4 + CTLs to IL15 might provide a means for promoting their antigen specific or bystander protective ability against a variety of patho gens or for enhancing the efficacy of antitumor therapies involving adoptive cells.
It is also possible, however, that in inflammatory disorders that involve IL15, such as celiac disease or virusinduced inflammatory conditions 32, 43 , CD4 + CTLs may increasingly become pathogenic effector cells that harmfully destroy their target tissue and recruit other cell types of the immune system, thereby contributing to inflam matory pathogenesis. In the context of celiac disease, it has been dif ficult to connect the known pathogenic factors, including dietary antigens, association with MHC class II, IL15 and TCRdepend ent and TCRindependent killer cells 18, 36 . Our finding that dietary antigen-induced, MHC class II-restricted CD4 + CTLs became potent cytotoxic effector cells, producing large amounts of IFNγ and TNF, when stimulated by their cognate antigen in the presence of IL15 may form the longsought 'missing link' that ties together the genetic and environmental factors involved in the pathogenesis of celiac disease.
In summary, the results presented here have identified CD4 + CTLs as distinct CD4 + effector cells defined by their postthymic loss of ThPOK and the reciprocal functional differentiation of these MHC class II-restricted T lymphocytes into CTLs. Our data have also identified the Thpok silencer as the molecular switch that drives the unique postthymic reprogramming of these CD4 + effector cells. The unexpected plasticity of mature CD4 + T cells in differentiating into CTLs expands the functional ability of MHC class II-restricted CD4 + effector cells to also include direct protective functions and provides the immune system with an alternative protective mecha nism, although the findings here have also demonstrated that these CD4 + CTLs may be central in driving the immunological pathology associated with inflammatory MHC class II-restricted T cells.
CD4 + effector cells with cytolytic functions have been known for a long time, and they have frequently been associated with beneficial as well as pathological immune responses. Nevertheless, progress in directly linking such cells to those events or targeting them as part of an immunological therapy has been extremely difficult mainly because they could not be separated from classic effector helper T cells. Therefore, the new insights reported here defining CD4 + CTLs as a distinct subset of effector cells and identifying the mechanism that leads to the unique differentiation of these cells provide informa tion to finally move forward the field of CD4 + CTLs and to specifically target these cells to enhance protective immunity or to prevent or treat inflammatory diseases and immunological pathology.
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